Insider transactions Novo Nordisk A/S

Stocks

Real-time Estimate Cboe Europe Other stock markets 07:27:36 17/07/2026 pm IST			5-day change	1st Jan Change
333.20 ^DKK	-0.77%		+4.25%	+3.29%

07:03pm	Novo Nordisk's Wegovy Gets Indian Regulator Nod to Treat Aggressive Fatty Liver Disease	MT
06:58pm	Novo Nordisk's Wegovy Approved for Fatty Liver Disease Treatment by India's Drug Regulator	MT

Date	Insider	Type	Main position	Quantity	Price	Amount	% Market Cap.
18/11/25	David Moore	Sell		8,160	297.95	24.31L	0.0002%
18/11/25	Stephan Engels	Buy	Director	6,450	312.50	20.16L	0.0002%
18/11/25	David Moore	Others		18,634	-	-	0.0005%
20/08/25	Christina Law	Buy	Director	598	349.04	2L	0.0000%
20/08/25	Christina Law	Buy	Director	952	349.06	3L	0.0000%
20/08/25	Christina Law	Buy	Director	800	349.03	3L	0.0000%
11/08/25	Ludovic Helfgott	Sell	Executive/Senior Manager	28,710	295.00	84.69L	0.0008%
07/08/25	Martin Lange	Sell	Chief Technology Officer	74	316.75	23.44T	0.0000%
07/08/25	Martin Lange	Sell	Chief Technology Officer	13,950	316.48	44.15L	0.0004%
04/11/21	Maziar Mike Doustdar	Sell	Chief Executive Officer	6,500	719.98	46.8L	0.0004%
11/08/21	Laurence Debroux	Buy	Director	38	638.50	24.26T	0.0000%
11/08/21	Laurence Debroux	Buy	Director	25	638.50	15.96T	0.0000%
11/08/21	Laurence Debroux	Buy	Director	42	638.50	26.82T	0.0000%
11/08/21	Laurence Debroux	Buy	Director	50	638.50	31.92T	0.0000%
11/08/21	Laurence Debroux	Buy	Director	45	638.50	28.73T	0.0000%
10/08/21	Anne Marie Handrup Kverneland	Sell	Director	158	636.10	1L	0.0000%
09/08/21	Martin MacKay	Buy	Director	500	639.96	3L	0.0000%